These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 22840745)

  • 1. Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention.
    Silva DF; Selfridge JE; Lu J; E L; Cardoso SM; Swerdlow RH
    Adv Pharmacol; 2012; 64():83-126. PubMed ID: 22840745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    Yu Q; Du F; Douglas JT; Yu H; Yan SS; Yan SF
    J Alzheimers Dis; 2017; 59(1):223-239. PubMed ID: 28598851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial biology in Alzheimer's disease pathogenesis.
    Galindo MF; Ikuta I; Zhu X; Casadesus G; Jordán J
    J Neurochem; 2010 Aug; 114(4):933-45. PubMed ID: 20492350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial therapeutic interventions in Alzheimer's disease.
    Van Giau V; An SSA; Hulme JP
    J Neurol Sci; 2018 Dec; 395():62-70. PubMed ID: 30292965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria as a therapeutic target in Alzheimer's disease and diabetes.
    Moreira PI; Cardoso SM; Pereira CM; Santos MS; Oliveira CR
    CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):492-511. PubMed ID: 19702564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease.
    de la Monte SM; Wands JR
    J Alzheimers Dis; 2006 Jul; 9(2):167-81. PubMed ID: 16873964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.
    Beal MF
    J Bioenerg Biomembr; 2004 Aug; 36(4):381-6. PubMed ID: 15377876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dying of the light: mitochondrial failure in Alzheimer's disease.
    Young-Collier KJ; McArdle M; Bennett JP
    J Alzheimers Dis; 2012; 28(4):771-81. PubMed ID: 22057028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of mitochondrial dysfunction in Alzheimer's disease.
    Castellani R; Hirai K; Aliev G; Drew KL; Nunomura A; Takeda A; Cash AD; Obrenovich ME; Perry G; Smith MA
    J Neurosci Res; 2002 Nov; 70(3):357-60. PubMed ID: 12391597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cAMP analog attenuates beta-amyloid (1-42)-induced mitochondrial dysfunction and spatial learning and memory deficits.
    Aghsami M; Sharifzadeh M; Sepand MR; Yazdankhah M; Seyednejad SA; Pourahmad J
    Brain Res Bull; 2018 Jun; 140():34-42. PubMed ID: 29605485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's Disease: From Mitochondrial Perturbations to Mitochondrial Medicine.
    Cardoso S; Carvalho C; Correia SC; Seiça RM; Moreira PI
    Brain Pathol; 2016 Sep; 26(5):632-47. PubMed ID: 27327899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction and Alzheimer's disease.
    Maruszak A; Żekanowski C
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):320-30. PubMed ID: 20624441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease.
    Onyango I; Khan S; Miller B; Swerdlow R; Trimmer P; Bennett P
    J Alzheimers Dis; 2006 Jul; 9(2):183-93. PubMed ID: 16873965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer's Disease.
    Adiele RC; Adiele CA
    J Alzheimers Dis; 2016 Jul; 53(4):1257-70. PubMed ID: 27392851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease.
    Hroudová J; Singh N; Fišar Z
    Biomed Res Int; 2014; 2014():175062. PubMed ID: 24900954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    Yu Q; Fang D; Swerdlow RH; Yu H; Chen JX; Yan SS
    J Alzheimers Dis; 2016 Sep; 54(2):679-90. PubMed ID: 27567872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant SkQ1 Alleviates Signs of Alzheimer's Disease-like Pathology in Old OXYS Rats by Reversing Mitochondrial Deterioration.
    Kolosova NG; Tyumentsev MA; Muraleva NA; Kiseleva E; Vitovtov AO; Stefanova NA
    Curr Alzheimer Res; 2017; 14(12):1283-1292. PubMed ID: 28637402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria, Cybrids, Aging, and Alzheimer's Disease.
    Swerdlow RH; Koppel S; Weidling I; Hayley C; Ji Y; Wilkins HM
    Prog Mol Biol Transl Sci; 2017; 146():259-302. PubMed ID: 28253988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.
    Selfridge JE; E L; Lu J; Swerdlow RH
    Neurobiol Dis; 2013 Mar; 51():3-12. PubMed ID: 22266017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.